Scalable, end-to-end discovery workflows
- Automate in vitro, in vivo, and in silico lead selection from Sanger or NGS data
- Access a comprehensive toolset from sequence annotation to liability analysis
- Tailored and live in 4-8 weeks

ENPICOM deploys both the software and the engineers
to match how your scientists want to organize data, automate workflows, bring AI to the bench, and explore results.



















In under three months, ENPICOM standardized our antibody discovery workflows around our existing SOPs, driving fast adoption and letting our scientists focus on the science.
— Executive Director, Top 10 pharma
ENPICOM automated the manual, error-prone steps, so we could move to new NGS technologies quickly and cut our timelines dramatically.
— Principal Scientist, Lab Head, Top 10 pharma
Weeks of DNA analysis across three platforms now finish in under an hour, and recovery lifted from 60% to 100%. Truly outstanding.
— Senior Scientist, Antibody Discovery
Most vendors hand you a platform.
At ENPICOM, we work with you and deliver the outcome.
Ensuring our solutions integrate with your science, your data, and your existing tools is our top priority. That's why we deploy a team that understands your biology alongside yours and helps you build the discovery workflows your scientists need.
Turning weeks into hours.


4–8 weeks, not a 12-month implementation project. We start with the biology: your modality, your data, your specs.
Built around your workflow, so there's no separate change-management project.
ML predictions inside the analysis view your scientists use ensure candidate selection moves at the speed of biology.
